Jonathan Fleming's Net Worth
$0
Who is Jonathan Fleming?
Jonathan Fleming does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Glori Energy Inc., Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc., AVALON PHARMACEUTICALS INC, Radius Health, Inc., Xencor Inc, ACADIA PHARMACEUTICALS INC, Ceres, Inc., SALMON EXPRESS INC, MEMORY PHARMACEUTICALS CORP, Solexa, Inc., IMCOR PHARMACEUTICAL CO, and CRITICARE SYSTEMS INC /DE/.
SEC CIK
Jonathan Fleming's CIK is 0001262294
Past Insider Trading and Trends
2004 was Jonathan Fleming's most active year for acquiring shares with 1 total transactions. Jonathan Fleming's most active month to acquire stocks was the month of May. 2009 was Jonathan Fleming's most active year for disposing of shares, totalling 1 transactions. Jonathan Fleming's most active month to dispose stocks was the month of December. 2004 saw Jonathan Fleming paying a total of $0.00 for 20,000 shares, this is the most they've acquired in one year. In 2009 Jonathan Fleming cashed out on 10,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trubion Pharmaceuticals, Inc No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +5,180.19% | 2.16M |
—
|
—
| 2.2M |
Oct 23
| |||
Form 4
|
∞
| 41.61K |
$13.00 | $540,982.00 | 41.61K |
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cyberkinetics Neurotechnology Systems, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.58% | 833.33K |
$1.20 | $1,000,000.80 | 10.54M |
Oct 18
| |||
Form 4
| +34.69% | 2.5M |
$1.20 | $3,000,000.00 | 9.71M |
Sep 26
| |||
Form 4
| +4.62% | 318.5K |
$3.00 | $955,503.00 | 7.21M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
| +22.78% | 586.4K |
$6.82 | $4,000,023.96 | 3.16M |
Apr 20
| |||
Form 4
| +112.31% | 2.6M |
$7.00 | $1,995,000.00 | 4.91M |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Solexa, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.14% | 552.01K |
$4.00 |
—
| 3.05M |
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AVALON PHARMACEUTICALS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +861.30% | 753.64K |
$10.50 | $1,904,700.00 | 841.14K |
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |